PV de délibération L1 SNV 2018-2019

PV de délibération L1 SNV 2018-2019

 

[embeddoc url=”https://medjouel.com/wp-content/uploads/2019/08/der-pv-deliberation-2019-L1.docx” download=”none” viewer=”microsoft”]

Check Also

A promising new treatment for Parkinson’s disease

Lixisenatide, a drug developed by Sanofi already used against type 2 diabetes, could slow the …

Leave a Reply

Your email address will not be published. Required fields are marked *